Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, et al
The placebo and bimagrumab 10 mg/kg groups switched to bimagrumab 30 mg/kg for the open-label extension period
For millions of families affected by Alzheimers, this research offers evidence-based hope
10.1016/j.jep.2021.113789 131 LiuW.WangX.ChenY.ZhangH.ChenJ.ZhangJ.et al (2022a)
They influence stability (how long the product remains potent), compatibility (whether ingredients interact with each other or with the syringe material), and tolerability (some excipients can cause injection site reactions in sensitive individuals)
In Korea, it's commonly associated with skin brightening, thanks to its ability to inhibit melanin production